logo
episode-header-image
Jun 2021
48m 17s

Special Episode: State of the Market Rou...

THE VOICE OF INSURANCE MARK GEOGHEGAN
About this episode

Today’s special episode does exactly what it says on the tin - plus a little more. AdvantageGo organised a prestigious panel of three prominent US-focused P&C CEOs and I got to work with them on dissecting the state of the market. Marc Adee, CEO of Crum & Forster, Andrew Robinson CEO of Skyward Specialty and Greg Hendrick the CEO of Vantage Group were all on excellent form as we examined rate adequacy, the prospect for loss trends and whether underwriters might keep ahead of them, resurgent economic and social inflation, the re-rating of cyber insurance and the ever-developing view of the industry Covid loss. We also rounded up the mid-year renewals, talked about the largely benign impact of reinsurance on the current market, and took a view on the sky-high valuations of public Insurtech stocks and the future of innovation and the industry’s developing relationship with technology. Many thanks again to AdvantageGo for organising this one – all I had to do was show up and ask the questions!

Enjoy the podcast.

NOTES

Greg Hendrick couldn't remember who said the famous quote about the market being able to stay irrational longer that you can stay solvent. This one is from the British economist John Maynard Keynes.

 

LINKS

We thank our naming sponsor AdvantageGo - enabling an enterprise view of exposure: https://www.advantagego.com/

Up next
Aug 15
Sp Ep Jeff Ward Ebix Europe: The Unquestionable Benefits of Data-First
Todays’ guest has been working on implanting the best technology into the London Market since the days when computer screens only displayed varying shades of green. He’s someone who I have known for twenty years and have come to rely upon to unpack all the jargon, spell out the a ... Show More
53m 23s
Aug 12
Ep264 Andrew McMellin: Putting Markel on the Map
The global, wholesale and specialty insurance and reinsurance segment of the global market has been putting out very strong results in recent times. If I had to highlight a consistent theme in my interviews of the past year, it would be an almost universal desire among carriers f ... Show More
40m 1s
Aug 8
Sp Ep Simon Pollack & Owen Whelan of Calibrant: Sledgehammers for Scalpels - Precision in Portfolio Management
Today's Episode is fun and insightful from start to finish and that is entirely down to my guests. One of the great Eureka moments in insurance comes when you meet an actuary who is a great communicator. Five minutes chatting to them usually unlocks understanding that would take ... Show More
44m 2s
Recommended Episodes
Feb 2025
Eli Lilly CEO: The Weight-Loss Drug Revolution, AI in Pharma, and Innovation
Nicolai Tangen meets with David Ricks, CEO of Eli Lilly, for a discussion about the pharmaceutical giant's remarkable journey. At the forefront is Eli Lilly's breakthrough work with weight reduction drugs, which are showing promise far beyond their original purpose - from treatin ... Show More
55m 40s
Feb 2025
HIGHLIGHTS: David Ricks - CEO of Eli Lilly
We've curated a special 10-minute version of the podcast for those in a hurry.   Here you can listen to the full episode: https://podcasts.apple.com/no/podcast/eli-lilly-ceo-the-weight-loss-drug-revolution-ai-in/id1614211565?i=1000693848152&l=nb Nicolai Tangen meets with David Ri ... Show More
10m 31s
Aug 2024
Prof G Markets: Is AI CapEx Out of Control? + Bill Ackman’s IPO Failure
Follow Prof G Markets: Apple Podcasts Spotify  Scott and Ed open the show by discussing the latest Fed meeting, Starbucks’ disappointing earnings, and Delta’s CrowdStrike problem. Then Scott shares his thoughts on Microsoft and Meta’s earnings and breaks down why capital expendit ... Show More
50m 44s
Oct 2024
What’s the Biggest Threat to the U.S. Economy’s Soft-Landing? — ft. Mark Zandi
Scott and Ed open the show by discussing Starboard Value’s activist stake in Pfizer, the end of the Longshoremen’s strike, and Ben Horowitz’s decision to donate to Kamala Harris’s campaign. Then Mark Zandi, Chief Economist of Moody’s Analytics, joins the show to discuss the recen ... Show More
58m 58s
Aug 6
BCG Presents: The CEO Radar
While discussions of US tariff policies dominated Q2 earnings calls to an unprecedented degree, another equally important trend is bubbling just under the surface in C-suites and on trading floors: concern that the economic uncertainty caused by tariff turmoil may lead to a downt ... Show More
15m 23s
Feb 2025
Ray Dalio on AI, Job Loss & the Future of the Economy | #EP 148
In this episode, Ray and Peter discuss the changing world order, China vs. the USA, and Ray’s thoughts on the future of the US. Recorded on Feb 3rd, 2025Views are my own thoughts; not Financial, Medical, or Legal Advice. Ray Dalio is a renowned investor, hedge fund manager, and p ... Show More
1h 46m
Apr 2025
Barry Ritholtz: Cutting Through Financial Noise - [Making Markets, EP.58]
My guest today is Barry Ritholtz. As the founder & CIO of Ritholtz Wealth Management Barry manages assets of over $5B. He is also a famous author and commentator, fondly known as the 'Prickly Prophet of Wall Street' for his contrarian views. In this conversation, Barry shares the ... Show More
1h 10m
Nov 2024
Stan Druckenmiller: Inside the mind of a legendary investor
This week, Nicolai Tangen visits Stan Druckenmiller in New York — one of the most renowned investors of our time, known for his insights into macroeconomics and markets. In this conversation, Druckenmiller shares his approach to major trades, like his groundbreaking bet against t ... Show More
57m 56s
Sep 2024
OpenAI’s Exodus, the Rise of Palantir, and the Longshoremen’s Strike
Scott and Ed open the show by discussing the DOJ’s antitrust lawsuit against Visa, Meta’s new AR glasses and the recent executive resignations at OpenAI. Then Scott explains why Palantir is one of the most overvalued companies in tech, and why he thinks the brand has resonated wi ... Show More
50m 17s
Mar 2021
S&P 500 Hits Record High One Year After COVID-Fueled Market Crash, A Street-High Call For Apple, Feeling "Lucid" about EVs, And An Exclusive With The Chairman Of Oxycontin Maker Purdue Pharma
Carl Quintanilla, Jim Cramer and David Faber took a closer look at the reopening trade including airline and cruise stocks on a day in which the S&P 500 hit a new all-time intraday high. They also discussed Evercore ISI raising its price target on Apple to a street-high $175 per ... Show More
43m 22s